DE69415757D1 - Zusammensetzung zur Vorbeugung und Behandlung von Myopie - Google Patents
Zusammensetzung zur Vorbeugung und Behandlung von MyopieInfo
- Publication number
- DE69415757D1 DE69415757D1 DE69415757T DE69415757T DE69415757D1 DE 69415757 D1 DE69415757 D1 DE 69415757D1 DE 69415757 T DE69415757 T DE 69415757T DE 69415757 T DE69415757 T DE 69415757T DE 69415757 D1 DE69415757 D1 DE 69415757D1
- Authority
- DE
- Germany
- Prior art keywords
- myopia
- treatment
- prophylaxis
- prevention
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25138393 | 1993-10-07 | ||
| JP1253794 | 1994-02-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69415757D1 true DE69415757D1 (de) | 1999-02-18 |
| DE69415757T2 DE69415757T2 (de) | 1999-06-10 |
Family
ID=26348167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69415757T Expired - Fee Related DE69415757T2 (de) | 1993-10-07 | 1994-10-05 | Zusammensetzung zur Vorbeugung und Behandlung von Myopie |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5519030A (de) |
| EP (1) | EP0647445B1 (de) |
| KR (1) | KR100193406B1 (de) |
| CN (1) | CN1108095A (de) |
| AT (1) | ATE175350T1 (de) |
| AU (1) | AU677860B2 (de) |
| BR (1) | BR9404007A (de) |
| CA (1) | CA2133805A1 (de) |
| CZ (1) | CZ244994A3 (de) |
| DE (1) | DE69415757T2 (de) |
| ES (1) | ES2126039T3 (de) |
| FI (1) | FI944687A (de) |
| HU (1) | HUT71112A (de) |
| NO (1) | NO943749L (de) |
| NZ (1) | NZ264616A (de) |
| PL (1) | PL305352A1 (de) |
| SK (1) | SK121394A3 (de) |
| TW (1) | TW282471B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5952338A (en) * | 1996-07-05 | 1999-09-14 | Takeda Chemical Industries, Ltd. | Agent for prophylaxis and treatment of disturbance of visual function |
| SE0002211D0 (sv) * | 2000-06-13 | 2000-06-13 | Synphora Ab | Methods and compositions for prevention of myopia |
| MD38Z5 (ro) * | 2009-02-20 | 2010-02-28 | Татьяна ГИДИРИМСКИЙ | Metodă de corecţie a vederii la slab văzători |
| WO2013022801A1 (en) | 2011-08-05 | 2013-02-14 | Forsight Vision4, Inc. | Small molecule delivery with implantable therapeutic device |
| CA2818612C (en) | 2010-11-19 | 2020-12-29 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
| US9968603B2 (en) | 2013-03-14 | 2018-05-15 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
| MY182793A (en) * | 2014-08-08 | 2021-02-05 | Forsight Vision4 Inc | Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4728509A (en) * | 1985-08-19 | 1988-03-01 | Takeda Chemical Industries, Ltd. | Aqueous liquid preparation |
| JPH06110587A (ja) * | 1992-09-28 | 1994-04-22 | Omron Corp | 自動取引き機の電源制御方法とその装置 |
-
1994
- 1994-09-29 US US08/314,685 patent/US5519030A/en not_active Expired - Fee Related
- 1994-10-04 AU AU74417/94A patent/AU677860B2/en not_active Ceased
- 1994-10-05 CZ CZ942449A patent/CZ244994A3/cs unknown
- 1994-10-05 ES ES94115648T patent/ES2126039T3/es not_active Expired - Lifetime
- 1994-10-05 NZ NZ264616A patent/NZ264616A/en unknown
- 1994-10-05 TW TW083109221A patent/TW282471B/zh not_active IP Right Cessation
- 1994-10-05 AT AT94115648T patent/ATE175350T1/de not_active IP Right Cessation
- 1994-10-05 EP EP94115648A patent/EP0647445B1/de not_active Expired - Lifetime
- 1994-10-05 DE DE69415757T patent/DE69415757T2/de not_active Expired - Fee Related
- 1994-10-06 FI FI944687A patent/FI944687A/fi not_active Application Discontinuation
- 1994-10-06 HU HU9402883A patent/HUT71112A/hu unknown
- 1994-10-06 CA CA002133805A patent/CA2133805A1/en not_active Abandoned
- 1994-10-06 BR BR9404007A patent/BR9404007A/pt not_active Application Discontinuation
- 1994-10-06 SK SK1213-94A patent/SK121394A3/sk unknown
- 1994-10-06 NO NO943749A patent/NO943749L/no unknown
- 1994-10-07 KR KR1019940025755A patent/KR100193406B1/ko not_active IP Right Cessation
- 1994-10-07 PL PL94305352A patent/PL305352A1/xx unknown
- 1994-10-07 CN CN94118637A patent/CN1108095A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0647445B1 (de) | 1999-01-07 |
| ATE175350T1 (de) | 1999-01-15 |
| NO943749L (no) | 1995-04-10 |
| HU9402883D0 (en) | 1995-01-30 |
| KR950010896A (ko) | 1995-05-15 |
| SK121394A3 (en) | 1995-07-11 |
| DE69415757T2 (de) | 1999-06-10 |
| EP0647445A1 (de) | 1995-04-12 |
| AU677860B2 (en) | 1997-05-08 |
| HUT71112A (en) | 1995-11-28 |
| CZ244994A3 (en) | 1995-04-12 |
| BR9404007A (pt) | 1995-06-13 |
| CA2133805A1 (en) | 1995-04-08 |
| NZ264616A (en) | 1997-06-24 |
| ES2126039T3 (es) | 1999-03-16 |
| US5519030A (en) | 1996-05-21 |
| NO943749D0 (no) | 1994-10-06 |
| PL305352A1 (en) | 1995-04-18 |
| FI944687A0 (fi) | 1994-10-06 |
| TW282471B (de) | 1996-08-01 |
| AU7441794A (en) | 1995-04-27 |
| KR100193406B1 (ko) | 1999-06-15 |
| FI944687A (fi) | 1995-04-08 |
| CN1108095A (zh) | 1995-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2029420A1 (en) | Pharmaceutical compositions and methods for inhibition of maillard's reaction | |
| DE68914292D1 (de) | Zusammensetzung zur Behandlung von ischämischen Störungen in Organen. | |
| DE69327328D1 (de) | Verwendund von norastemizol zur behandlung der allergischen rhinitis | |
| ZA89389B (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
| EP0285278A3 (en) | Method of treating anxiety with tetrahydrobenzûc,d¨indole-6-carboxamides | |
| DE69415757D1 (de) | Zusammensetzung zur Vorbeugung und Behandlung von Myopie | |
| DE69418744T2 (de) | Verwendung von Pregnanderivaten zur Behandlung von Tumoren | |
| DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
| RU94035672A (ru) | Композиция для профилактики и лечения близорукости, способ ее получения | |
| DE69327077T2 (de) | Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen | |
| ZA885358B (en) | Uricosuric composition | |
| ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
| ATE81465T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. | |
| TH17660A (th) | สารผสมสำหรับป้องกันและรักษาสายตาสั้น | |
| TH17660EX (th) | สารผสมสำหรับป้องกันและรักษาสายตาสั้น |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |